UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005400
Receipt number R000006407
Scientific Title Clinical trial of cultivated autologous oral mucosal epithelial cell sheet transplantation for corneal epithelial stem cell deficiency
Date of disclosure of the study information 2011/04/08
Last modified on 2017/10/10 12:37:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial of cultivated autologous oral mucosal epithelial cell sheet transplantation for corneal epithelial stem cell deficiency

Acronym

Cultivated oral mucosal epithelial cell sheet transplantation

Scientific Title

Clinical trial of cultivated autologous oral mucosal epithelial cell sheet transplantation for corneal epithelial stem cell deficiency

Scientific Title:Acronym

Cultivated oral mucosal epithelial cell sheet transplantation

Region

Japan


Condition

Condition

Bilateral corneal epithelial stem cell deficiency: Patients with severe intractable ocular surface disease who have dysfunction of the entire limbus with totally replaced by conjunctival epithelium, neovascularization and corneal scarring tissue. (*Corneal epithelial stem cell deficiency: It is possible to make the diagnosis by using slit lamp microscopy showing loss of the palisades of Vogt (POV) and a conjunctivalized corneal surface which also can be seen by characteristic fluorescein staining patterns easily.)

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of cultivated autologous oral mucosal epithelial cell sheet transplantation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To evaluate a size of epithelial defect and conjunctivalized corneal surface area in first postoperative year.

Key secondary outcomes

1. Improved visual acuity
2. Improved corneal opacity
3. Improved corneal neovascularization
4. Expected eye complications
5. All adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

Harvest of the oral mucosal tissue is conducted at the operation room of the out patient unit of department of ophthalmology or medical center for translational research in Osaka University Hospital. The safety of harvest process of the oral mucosal tissue is evaluated carefully. The oral mucosal tissue is harvested from the cheek mucosa after local anesthesia. The size of the oral mucosal tissue would be 5 mm square and 3-4 mm in depth. The site of harvest is sutured for blood stanching and observed during the early follow-up period.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Total limbal stem cell deficiency
2) Entire corneal surface is covered by conjunctival tissue
3) Regardless of gender, and must be over 20 years old when the subjects agree with this project
4) The signed consent is required

At least one eye have to fully meet the criteria

Key exclusion criteria

1) Subjects who are pregnant, plan to become pregnant, or are breast-feeding.
2) Subjects who have systemic infections (HBV, HCV, HIV, HTLV-1)
3) Subjects who have extremely severe dry eye
4) Subjects who have extensive oral mucosal scarring and impossibile to obtain the oral mucosal tissue.
5) Subjects whose performance status is scored over 3 points.
6) Subjects who are not unsuitable for this project by some complications (judged by the docter in charge).

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kohji Nishida

Organization

Osaka University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code


Address

2-2, Yamada-oka, Suita, Osaka

TEL

+81-6-6879-3456

Email

knishida@ophthal.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takeshi Soma

Organization

Osaka University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code


Address

2-2, Yamada-oka, Suita, Osaka

TEL

+81-6-6879-3456

Homepage URL


Email

soma@ophthal.med.osaka-u.ac.jp


Sponsor or person

Institute

Department of Ophthalmology, Osaka University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Grant from Osaka University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院(大阪府)


Other administrative information

Date of disclosure of the study information

2011 Year 04 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 01 Month 04 Day

Date of IRB


Anticipated trial start date

2011 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 04 Month 07 Day

Last modified on

2017 Year 10 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006407


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name